Hair Loss Treatment with PRP: The Honest Candidate Guide — Who Responds, Who Doesn’t, and the Activated Protocol Difference That Determines Your Outcome

Introduction: The PRP Conversation Most Clinics Won’t Have With You

Androgenetic alopecia (AGA) is the most common form of hair loss on the planet. In the United States alone, it affects an estimated 50 million men and 30 million women, and by age 70, up to 80% of men and 50% of women will develop it. That is a staggering number of people searching for answers, which is exactly why platelet-rich plasma (PRP) has become one of the most talked-about hair restoration treatments available today.

Unfortunately, the way PRP gets discussed rarely helps the people considering it. It is either oversold as a guaranteed miracle cure or buried in clinical jargon that leaves patients more confused than when they started. This article takes neither approach.

By the end, readers will understand the biological mechanism in plain language, know exactly where they fall on the candidacy spectrum, understand why activated PRP and combination protocols matter so much, and know precisely what questions to ask any provider before committing. The honest framing is this: PRP delivers strong results for the right candidates and limited results for the wrong ones. Knowing the difference is the entire game.

At Hair Transplant Specialists, PRP is approached as one evidence-based tool within a broader, personalized hair restoration strategy, not as a one-size-fits-all product sold to everyone who walks through the door.

What PRP Actually Does: The Biology in Plain English

PRP is a concentrated preparation of a patient’s own blood platelets, typically reaching four to eight times the platelet concentration of whole blood. That concentrate is used to deliver a payload of growth factors directly to the scalp.

The process has three straightforward steps: a small blood draw, centrifuge separation to isolate the platelet-rich layer, and injection into the scalp. Because the material comes from the patient’s own body (it is autologous), the risk of systemic allergic reaction is minimal.

One misconception needs clearing up immediately: PRP contains no stem cells. It is a growth factor delivery vehicle, not a stem cell therapy. What it delivers is a cocktail of signaling proteins, including:

  • PDGF (platelet-derived growth factor): triggers cell proliferation, essentially waking up dormant follicles.
  • VEGF (vascular endothelial growth factor): builds new blood supply to the follicle.
  • EGF (epidermal growth factor): supports epithelial tissue growth.
  • FGF (fibroblast growth factor): helps regulate the follicle’s growth cycling.
  • TGF-β (transforming growth factor beta): aids tissue remodeling.
  • IGF-1 (insulin-like growth factor 1): extends the anagen, or active growth, phase.

Underlying all of this is a signaling pathway called Wnt/β-catenin. In AGA, the chemical signals that tell follicles to keep growing get disrupted. PRP growth factors help restore those signals. In practical terms, dormant follicles are reactivated, the active growth phase is extended, and blood supply to each follicle improves. Over time, that translates into reduced shedding and increased density.

Rigorous providers are also honest about the limits of current knowledge. The ISHRS acknowledges that PRP contains more than 30 bioactive substances and that the exact mechanism remains incompletely understood. That intellectual honesty is a good sign, not a red flag.

Who Responds Best: Using Hair Loss Staging to Predict Your Outcome

Here is the single most important principle in this entire guide: PRP requires viable, living follicles to stimulate. It cannot resurrect follicles that have permanently died. This one fact explains most of the variation in patient outcomes.

To predict who will respond, clinicians use standardized staging systems: the Hamilton-Norwood Scale for men and the Ludwig Scale for women. These tools matter not just for surgical planning but for PRP candidacy, because they estimate how many active follicles remain to be stimulated.

The Hamilton-Norwood Scale: PRP Candidacy for Men

The Hamilton-Norwood scale runs from Type I (minimal or no recession) to Type VII (extensive baldness with only a horseshoe rim of hair remaining).

  • Strong candidates (Types I–III): Early recession or thinning with mostly active follicles. PRP achieves 70 to 80% success rates at these stages, with the best outcomes when treatment starts within the first year of noticeable thinning.
  • Moderate candidates (Types III–IV): Meaningful thinning, but follicles are still present and potentially responsive. PRP can stabilize loss and improve density, especially within a combination protocol.
  • Poor candidates (Types V–VII): Advanced baldness with significant follicle death. Success rates fall to 30 to 40% because there are not enough viable follicles to stimulate. PRP alone is unlikely to produce meaningful cosmetic improvement at these stages.

The lesson is consistent across the research: earlier intervention produces better outcomes. For anyone considering treatment, that is a strong reason to act sooner rather than later.

The Ludwig Scale: PRP Candidacy for Women

The Ludwig Scale (Types I–III) describes female pattern hair loss (FPHL), which tends to present as diffuse thinning across the crown rather than a receding hairline.

A common misconception is that PRP is mainly for men. The data says otherwise. Female patients report 75 to 85% satisfaction rates, compared with 70 to 75% for men, making women equal or superior responders.

A Mayo Clinic clinical trial specifically validated PRP for female androgenetic alopecia, lending high-authority institutional support to its use in women. For both sexes, younger patients (under 40) tend to achieve superior outcomes thanks to greater follicle regenerative capacity.

Who Should Not Pursue PRP: The Honest Contraindication List

Knowing when PRP is not the right option saves time and disappointment.

Absolute contraindications include platelet dysfunction syndrome, very low platelet count (thrombocytopenia), active scalp infections, bloodstream infections (septicemia), and severe blood circulation disorders.

Relative contraindications requiring careful evaluation include use of blood thinners or immunosuppressants, autoimmune conditions that attack hair follicles (such as active-phase alopecia areata), and scarring alopecia, in which follicles have been permanently destroyed.

Advanced-stage AGA is not a medical contraindication, but it is a practical one. When follicles are no longer viable, PRP has nothing left to stimulate.

Anyone in these categories should discuss alternatives, such as hair transplant surgery, exosome therapy, or scalp micropigmentation, with a qualified specialist rather than pursuing PRP.

The Activated Protocol Difference: Why Not All PRP Is Created Equal

There is no universally standardized PRP preparation protocol. Outcomes vary dramatically between providers depending on how the PRP is prepared and administered.

The key variables include centrifuge type and speed (single versus double spin), the platelet concentration achieved, the activation method (or lack thereof), injection depth and distribution pattern, and session spacing. Of all these, the activated versus non-activated distinction is the most clinically significant.

Activated vs. Non-Activated PRP: What the 2025 Evidence Shows

The most comprehensive evidence available comes from a landmark 2025 systematic review and meta-analysis published in Dermatology and Therapy, which analyzed 43 randomized controlled trials involving 1,877 participants.

The key finding: activated PRP significantly outperforms non-activated PRP in increasing hair density and minimizing recurrence. Equally important, non-activated PRP was associated with a higher frequency of adverse effects, meaning the activated protocol is not only more effective but also safer. In plain terms, activation (typically using calcium chloride or thrombin) triggers platelets to release their growth factors more completely and rapidly, maximizing the therapeutic signal delivered to the follicles. The practical takeaway for patients: ask any provider whether they use activated PRP and what activation agent they use. A provider who cannot answer that question clearly is a red flag. A 2026 review in the Journal of Cosmetic Dermatology further supports protocol optimization as the primary driver of outcome variability.

Other Protocol Variables That Separate Quality Providers

  • Platelet concentration: Quality PRP should reach four to eight times the platelet concentration of whole blood.
  • Single vs. double spin: Double-spin protocols generally achieve higher concentration and purity.
  • Injection technique: Depth, distribution, and volume per site determine how evenly growth factors reach the treatment area.
  • Session spacing: The evidence-based standard is three to four initial sessions spaced four to six weeks apart, followed by maintenance every 12 to 18 months.

Before committing, patients should ask any provider the following questions:

  1. Do you use activated PRP, and what activation agent?
  2. What platelet concentration does your system achieve?
  3. Do you use a single or double spin protocol?
  4. How many sessions do you recommend for my stage of hair loss?
  5. Do you recommend PRP as part of a combination protocol?
  6. What results have you seen in patients at my stage of loss?

Why PRP Monotherapy Is Often Not Enough: The Case for Combination Protocols

The 2026 clinical consensus is direct: combination protocols consistently outperform PRP monotherapy, with studies showing up to 50% better outcomes when PRP is paired with complementary treatments.

The logic is straightforward. PRP stimulates follicles and extends the growth phase, but it does not address the underlying DHT-driven miniaturization process that causes AGA. Combination therapy attacks the problem from multiple angles simultaneously. This is not upselling; it is the evidence-based standard of care for meaningful, lasting results.

PRP + Minoxidil: The Most Studied Combination

A meta-analysis of six studies found that PRP plus minoxidil outperformed either treatment alone for both density and thickness. Minoxidil increases blood flow and extends the anagen phase through a different pathway than PRP, creating an additive effect. It is FDA-approved for both men and women, making this combination broadly applicable.

PRP + Finasteride (Men) and Other Medical Therapies

Finasteride reduces DHT production, addressing the root hormonal cause of AGA in men. Where PRP stimulates follicles, finasteride protects them from ongoing miniaturization, showing 85% or greater stabilization or improvement after five years.

The side effect profiles differ meaningfully. Finasteride carries potential hormonal and sexual side effects, while PRP has no systemic effects, no sexual side effects, and no hormonal impact. This distinction is an important consideration for men who cannot tolerate finasteride. Low-Level Light Therapy (LLLT) is another evidence-supported partner, stimulating follicles through photobiomodulation via a distinct biological pathway.

PRP as a Hair Transplant Adjunct: A Powerful but Underappreciated Role

One of PRP’s most compelling uses is rarely discussed: improving hair transplant graft survival. In a randomized study of 40 hair transplant patients, 100% of those given PRP had over 75% follicle growth, compared with only 20% in the non-PRP group.

The mechanism is well-supported. PRP growth factors accelerate healing, reduce inflammation, and support neovascularization (new blood vessel formation) around transplanted grafts. This positions PRP as a natural complement to FUE and FUT procedures rather than a competing option, a point supported by a 2026 review of adjunctive regenerative therapies in hair transplantation.

What to Expect: Your PRP Treatment Timeline Month by Month

The following is the realistic patient journey that most content leaves out.

  • Pre-treatment: Consultation, candidacy assessment using Hamilton-Norwood or Ludwig staging, baseline photography, and discussion of a combination protocol if appropriate.
  • Treatment day: A brief blood draw (typically 20 to 60 ml), centrifuge processing (15 to 30 minutes), topical anesthetic, then injection across the treatment area. The full appointment usually runs 60 to 90 minutes.
  • Weeks 1–3 (the patience phase): Mild scalp redness and swelling for 24 to 48 hours, with minor tenderness at injection sites. Some patients notice temporary increased shedding, which is a normal part of the follicle cycling response, not a sign of failure. Reduced shedding typically begins within two to three weeks.
  • Months 1–3: The waiting period. Hair cycling takes time, so most patients see no visible density change yet, even though the biological process is underway.
  • Months 3–4: First visible improvements. Increased density and reduced shedding become noticeable, and satisfaction begins to climb.
  • Months 4–6: Peak initial results from the first course. Studies consistently report 30 to 40% increases in hair density, with one large multi-center dataset reporting an average increase of 45.9 hairs/cm² after three initial treatments.
  • Months 12–18: Maintenance timing. Without maintenance, results gradually fade as the growth factor stimulus wanes.

The honest bottom line: PRP is not a one-time cure. It is an ongoing maintenance strategy, much like managing any other chronic condition.

The Off-Label Status of PRP: What Honest Providers Tell You

Here is the regulatory reality, stated plainly. PRP is used off-label for hair loss in the United States. The devices used to prepare PRP are FDA-cleared under 510(k) pathways, but PRP itself has not received FDA approval as a standalone drug or biologic specifically for hair restoration.

Off-label use is common, legal, and often evidence-supported. Many widely accepted treatments are used this way. What matters is that the practice is backed by clinical evidence, which PRP for AGA increasingly is. A 2025 JAAD publication highlighted PRP as one of the few non-surgical therapies capable of producing sustained improvements in hair density, thickness, and patient satisfaction across both men and women with AGA.

The absence of an FDA-mandated protocol is precisely why provider selection and protocol quality matter so much, and why the protocol questions outlined earlier are essential. The ISHRS formally acknowledges PRP’s off-label status while recognizing its growing evidence base. A clinic that discloses this openly is more trustworthy than one that implies FDA approval.

PRP vs. Other Non-Surgical Hair Loss Treatments: How It Fits the Landscape

The following is a decision-making framework, not a sales pitch for any single treatment.

  • PRP vs. Minoxidil: Minoxidil is FDA-approved, lower cost, and requires daily application. PRP requires periodic in-office sessions but carries no daily compliance burden and no systemic side effects. They work best together. Learn more about oral vs. topical minoxidil to understand which form may suit your protocol.
  • PRP vs. Finasteride (men): Finasteride addresses the hormonal root cause; PRP stimulates follicle activity. Finasteride carries potential sexual side effects; PRP does not. Combined, they outperform either alone.
  • PRP vs. LLLT: Both are non-invasive and non-hormonal. LLLT works through photobiomodulation; PRP works through growth factor delivery. Their complementary mechanisms make them effective together.
  • PRP vs. Exosomes: Exosomes are an emerging frontier. A 2024 systematic review found they produced comparable or greater effect sizes to PRP in early-phase studies. The PRP-exosome combination is increasingly used for moderate-to-advanced AGA and may suit patients who have plateaued on PRP alone.
  • PRP vs. Hair Transplant Surgery: PRP is not a substitute for surgery when follicle loss is significant. For early-to-moderate AGA, it can delay or reduce the eventual need for surgery, and for surgical candidates, it dramatically improves graft survival.
  • Alma TED offers a needle-free delivery method for hair growth serums, relevant for needle-averse patients.

For most patients, the most effective approach is a personalized, multi-modal protocol, not a single treatment chosen in isolation.

Why Hair Transplant Specialists’ Approach to PRP Is Different

Hair Transplant Specialists is committed to evidence-based protocols: the activated PRP distinction, thoughtful combination therapy integration, and a candidacy-first consultation approach.

That commitment is backed by depth of experience. Dr. Sharon Keene is a former President of the ISHRS (2014–2015) and a recipient of the Platinum Follicle Award for outstanding achievement in basic scientific or clinically-related research. Together, the team brings more than 100 years of combined practice, which means PRP decisions are made by surgeons with genuine expertise across the full spectrum of hair restoration.

PRP is evaluated within the context of each patient’s complete journey, never sold as a standalone product. Because the practice offers the full toolkit (FUE, FUT, PRP, LLLT, Alma TED, exosome therapy, and scalp micropigmentation), recommendations are driven by patient need rather than by whatever a clinic happens to have on the shelf. As the practice puts it: “It’s not just about the procedure; it’s about you and your journey.”

Conclusion: The Honest Summary — Is PRP Right for You?

Here is the decision guide distilled.

A patient is likely a strong candidate if they are in the early-to-moderate stages of hair loss (Hamilton-Norwood I–IV or Ludwig I–II), their loss began within the last few years, they have no contraindications, and they are prepared for a multi-session, ongoing maintenance commitment.

A patient may be a moderate candidate if they are in the mid-range of staging with some follicle miniaturization. PRP within a combination protocol may still deliver meaningful results.

PRP is unlikely to be the best primary option if a patient has advanced-stage loss with significant follicle death, scarring alopecia, active autoimmune hair loss, or relevant medical contraindications. Surgical restoration or exosome therapy may serve those patients better.

Wherever treatment is pursued, asking the protocol questions outlined in this guide is essential. Provider quality and preparation protocol are the variables most within a patient’s control. PRP as part of a personalized, multi-modal plan consistently outperforms PRP alone. The single most important step is an honest, thorough consultation with a specialist who evaluates the patient’s specific stage, health history, and goals, not one who hands every patient the same protocol.

Ready to Find Out If You’re a PRP Candidate? Schedule Your Consultation

For those who have done their research and want a personalized assessment, a consultation is the logical next step.

Hair Transplant Specialists offers comprehensive consultations that include hair loss staging, candidacy assessment, and a personalized treatment plan discussion covering both non-surgical options like PRP and surgical options when appropriate.

  • Phone: (651) 393-5399
  • Website: INeedMoreHair.com
  • Location: 2121 Cliff Dr. Suite 210, Eagan, MN 55122
  • Hours: Monday–Thursday 9 AM–5 PM, Friday 9 AM–3 PM, Saturday and Sunday by appointment.

The goal of the consultation is simple: to give each person a clear, honest picture of their options, not to sell a treatment that is not right for them.